Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial (Q38230839)

From Wikidata

Jump to navigation Jump to search

scientific article published on 15 July 2014

Language	Label	Description	Also known as
English	Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial	scientific article published on 15 July 2014

Statements

scholarly article

1 reference

Europe PubMed Central

31 August 2017

Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial (English)

1 reference

Europe PubMed Central

31 August 2017

phase III clinical trial

0 references

0 references

zoledronic acid

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Caroline Wilson

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Peter Barrett-Lee

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Samantha Hinsley

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

Robert Coleman

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

David Cameron

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

David Dodwell

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Richard Bell

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Emma Rathbone

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Maccon Keane

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Miguel Gil

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Roger Burkinshaw

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Robert Grieve

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Diana Ritchie

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Victoria Liversedge

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

AZURE investigators

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

15 July 2014

1 reference

Europe PubMed Central

31 August 2017

Lancet Oncology Commission

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

997-1006

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Preparing the "soil": the premetastatic niche

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer to bone: a fatal attraction

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms of bone metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of bone-targeted agents on cancer progression and mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Breast-cancer adjuvant therapy with zoledronic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Endocrine therapy plus zoledronic acid in premenopausal breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of oral clodronate on bone mass, bone turnover and subsequent metastases in women with primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01-04) for women with stage II/III breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Osteonecrosis of the jaw and oral health-related quality of life after adjuvant zoledronic acid: an adjuvant zoledronic acid to reduce recurrence trial subprotocol (BIG01/04).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow: a long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Ten-year follow-up of a randomized controlled trial of adjuvant clodronate treatment in node-positive breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Bisphosphonate treatment in primary breast cancer: results from a randomised comparison of oral pamidronate versus no pamidronate in patients with primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone turnover across the menopause transition : The role of gonadal inhibins.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(14)70302-X

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

10.1016/S1470-2045(14)70302-X

0 references

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

2-s2.0-84905007644

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38230839&oldid=1748717024"